Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.
about
Genetic variations of the hepatitis B virus and their clinical relevanceB cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure.Circulating immune complexes in patients with fulminant hepatic failure.Hepatitis type A, B, and non-A non-B in fulminant hepatitis.Serological markers in fulminant hepatitis BHepatitis B virus DNA in children's liver diseases: detection by blot hybridisation in liver and serum.Serological responses to HBV infection.Multiplication of hepatitis B virus in fulminant hepatitis B.Fatal acute liver failure with hepatitis B virus infection during nataluzimab treatment in multiple sclerosisImmune mediated liver failure.Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levelsTreatment of a case of fulminant hepatic failure with continuous infusion of prostaglandin (PGE1).Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemicComplement activation and disease: protective effects of hyperbilirubinaemia.HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions.Fulminant hepatitis A.Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India.Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus.Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B.Anti-pre-S antibodies in different groups of patients with hepatitis B virus infection.Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.Fulminant hepatitis in infants in Taiwan: Strong association with hepatitis B e antigen-negative but antibody-positive maternal hepatitis B surface antigen carriage
P2860
Q28298591-C269D657-C6E5-4052-912B-6968EA9D99ECQ33928288-8ACD378C-8C4F-42C5-BE55-67B9A9F352B8Q34494264-CF83A1C5-EE5B-45D9-AA04-C8A0463400FBQ34494704-CE5FBF29-6321-4DBD-8CFA-6FAB7DD4BC2FQ34496026-5A343A47-D031-4F63-B2D7-9C7CBEF6B45DQ34496070-DA952AA5-988C-48A6-BC7B-282E97786E23Q34529889-4A0AB582-4E8C-4C10-9602-E1E9B8CEE3F6Q34555283-ECB492B1-5805-4A22-84B4-2476234B2467Q35105736-87EE5F39-A2E5-467C-8670-B644E23649FEQ35729249-C110191B-DCC2-4CD4-BFD2-E5548335DE0DQ35738189-FEB9F3F0-CDFC-4108-B009-3691D17B217DQ35948414-D089F224-669C-479A-970B-E64E468BFC6EQ36535912-FBA6C2F3-D038-4BAC-AF69-AECDE78D92FFQ37609484-CD666F1E-10A2-40DD-BB85-7ED85842837EQ37708054-B4714758-6DC7-4A7B-BC2A-2F400B126F84Q40287527-8A58CC05-6D5A-4425-A417-550715228CFEQ41841810-022E9F13-2BA6-4DAA-B8BE-AB7C529E620CQ42262369-40C396DA-B19C-40EC-9EFA-31B67AE0C15EQ45756207-E28A4D03-C579-49AE-A2B3-E8208D20C941Q45833800-AA201943-3787-4BF6-8A3C-CDE3CF2F2254Q45846851-D2DD4558-D2C9-482F-AA82-570419A40A31Q50865774-F7274103-D498-4F11-B9D6-F1E468CDE208Q57205828-BDDFC5ED-1A7E-47D5-AC4F-8552C7DE23A2
P2860
Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.
description
1976 nî lūn-bûn
@nan
1976 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@ast
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@en
type
label
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@ast
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@en
prefLabel
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@ast
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@en
P2093
P2860
P356
P1433
P1476
Hepatitis B antigen (HBSAg) an ...... c and prognostic significance.
@en
P2093
P2860
P356
10.1136/GUT.17.1.10
P407
P577
1976-01-01T00:00:00Z